Diabetic Cataracts and Flavonoids
- 14 January 1977
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 195 (4274) , 205-206
- https://doi.org/10.1126/science.401544
Abstract
Oral administration of quercitrin, an inhibitor of aldose reductase, leads to a significant decrease in the accumulation of sorbitol in the lens of diabetic Octodon degus. The onset of cataract is effectively delayed when quercitrin is continuously administered. Thus in these diabetic animals, as in galactosemic rats, the use of an effective aldose reductase inhibitor impedes the course of cataract development. These observations support the hypothesis that in diabetes, as in galactosemia, aldose reductase plays a key role in initiating the formation of lens opacity.This publication has 4 references indexed in Scilit:
- Inhibition of lens aldose reductase by flavonoids—Their possible role in the prevention of diabetic cataractsBiochemical Pharmacology, 1976
- Flavonoids as Inhibitors of Lens Aldose ReductaseScience, 1975
- Sorbitol pathway in diabetic and galactosemic rat lensBiochimica et Biophysica Acta (BBA) - General Subjects, 1974
- Polyol Accumulation in Galactosemic and Diabetic Rats: Control by an Aldose Reductase InhibitorScience, 1973